# Hepatectomy Versus Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to Major Blood Vessels

> **NCT00814242** · PHASE2,PHASE3 · COMPLETED · sponsor: **Eastern Hepatobiliary Surgery Hospital** · enrollment: 120 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** surgical resection
- **PROCEDURE:** percutaneous radiationfrequency ablation

## Key facts

- **NCT ID:** NCT00814242
- **Lead sponsor:** Eastern Hepatobiliary Surgery Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-12
- **Final completion:** 2011-11
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2016-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00814242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00814242, "Hepatectomy Versus Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to Major Blood Vessels". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00814242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*